By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Chemin Messidor 5-7
Case Postale 5911
Lausanne    CH - 1002  Switzerland
Phone: 41-21-321-0111 Fax: 41-21-321-0169


Company News
Debiopharm Regains Full Rights To Alisporivir Program 1/12/2015 7:16:22 AM
FDA Grants Fast Track Designation To Debiopharm's Antibiotic Debio 1450 1/8/2015 7:57:38 AM
Presented By The Japanese Cancer Association And Debiopharm Group™, The 'JCA-Mauvernay Award 2014' Goes To Doctors Hara And Shibata 9/29/2014 8:37:57 AM
Debiopharm And Nobelex Biotech Start Two Collaborations On Development Of New Antibiotics Against N. Gonorrhoeae And Enteric Species 6/26/2014 10:06:15 AM
Debiopharm And TCG Lifesciences Announce Successful Completion Of First Phase Of Research Collaboration On Discovery Of Novel Antibiotics 6/24/2014 9:18:59 AM
Debiopharm Announces Initiation Of A Phase I Study Of Debio 1450, An IV/Oral Potent Antibiotic Active Against Staphylococcal Infections 6/19/2014 6:33:16 AM
Debiopharm Moves Forward Three Of Its Oncology Clinical Programs And Will Present The Recent Progresses At The 50th American Society of Clinical Oncology Annual Meeting 5/28/2014 6:54:29 AM
Orient Europharma Co., Ltd. And Debiopharm Announce Their Partnership And The Launch Of Pamorelin®LA In Singapore 5/27/2014 11:44:48 AM
Debiopharm And Yale University Extend And Broaden Their Collaboration For The Discovery And Development Of MIF Inhibitors To Treat Autoimmune And Inflammatory Diseases 5/6/2014 9:30:59 AM
Curis, Inc. (CRIS) And Debiopharm Report Preclinical Data For Debio 0932 At American Association for Cancer Research Annual Meeting 2014 4/8/2014 7:48:36 AM